Literature DB >> 23361156

Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?

E K Calton1, V S Miller, M J Soares.   

Abstract

BACKGROUND AND OBJECTIVES: The pathogenesis of the metabolic syndrome (MetS) is not well understood. This review is based on the hypothesis that both traditional and emerging risk factors act through adiponectin. SUBJECTS AND METHODS: We conducted a search of the literature using prominent electronic databases and search terms that included in combination: adiponectin, diet, dietary patterns, exercise, metabolic rate, MetS and testosterone. Articles were restricted to studies conducted on adult humans, reported in English and within the time period 2000-2012. RESULTS AND
CONCLUSIONS: Both traditional and emerging risk factors associated with the MetS show some evidence of exerting their influence through adiponectin. High-quality randomized controlled trials that alter adiponectin levels are required to further corroborate this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361156     DOI: 10.1038/ejcn.2013.1

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  14 in total

1.  Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.

Authors:  Hongmei Zhang; Yixin Niu; Hongxia Gu; Shuai Lu; Weiwei Zhang; Xiaoyong Li; Zhen Yang; Li Qin; Qing Su
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

2.  Addition of Exercise Increases Plasma Adiponectin and Release from Adipose Tissue.

Authors:  Xuewen Wang; Tongjian You; Karin Murphy; Mary F Lyles; Barbara J Nicklas
Journal:  Med Sci Sports Exerc       Date:  2015-11       Impact factor: 5.411

Review 3.  The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.

Authors:  E K Calton; K N Keane; P Newsholme; Y Zhao; M J Soares
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

4.  Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease?

Authors:  Srinivasan Dasarathy
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

5.  Cut-off value of total adiponectin for managing risk of developing metabolic syndrome in male Japanese workers.

Authors:  Akiko Hata; Koji Yonemoto; Yosuke Shikama; Nanako Aki; Chisato Kosugi; Ayako Tamura; Takako Ichihara; Takako Minagawa; Yumi Kuwamura; Masashi Miyoshi; Takayuki Nakao; Makoto Funaki
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype.

Authors:  Andrea Guennoun; Melissa Kazantzis; Remy Thomas; Martin Wabitsch; Daniel Tews; Konduru Seetharama Sastry; Mouaadh Abdelkarim; Vladimir Zilberfarb; Arthur Donny Strosberg; Lotfi Chouchane
Journal:  J Transl Med       Date:  2015-04-30       Impact factor: 5.531

Review 7.  New insight into adiponectin role in obesity and obesity-related diseases.

Authors:  Ersilia Nigro; Olga Scudiero; Maria Ludovica Monaco; Alessia Palmieri; Gennaro Mazzarella; Ciro Costagliola; Andrea Bianco; Aurora Daniele
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

8.  Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome.

Authors:  Maria Luz Fernandez; Ana Gabriela Murillo
Journal:  Healthcare (Basel)       Date:  2016-03-16

9.  Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in Type 2 diabetic subjects.

Authors:  Catherine B MarElia; Melanie N Kuehl; Tiffany A Shemwell; Amy C Alman; Brant R Burkhardt
Journal:  J Clin Transl Endocrinol       Date:  2018-02-23

10.  Plasma Adiponectin Levels in Elderly Patients with Prediabetes.

Authors:  Si Eun Kong; Yea Eun Kang; Kyong Hye Joung; Ju Hee Lee; Hyun Jin Kim; Bon Jeong Ku
Journal:  Endocrinol Metab (Seoul)       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.